NEUROLOGICAL MANIFESTATIONS OF FABRY DISEASE IN CHILDREN AND ADOLESCENTS
Fabry disease (Anderson–Fabry disease) is an X-linked recessive lysosomal storage disorder resulting from deficient activity of lysosomal hydrolase, alpha-galactosidase A, which leads to progressive accumulation of globotriaosylceramide (Gb3) in various cells (predominantly endothelial and vascular...
Saved in:
| Main Authors: | A. S. Kotov, K. V. Firsov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2017-12-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/227 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease
by: V. I. Ignatyeva, et al.
Published: (2019-01-01) -
Current treatment status of fabry disease in South Korea: a longitudinal National health insurance service data-based study
by: DoHyeon Lee, et al.
Published: (2025-07-01) -
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy
by: Uma Ramaswami, et al.
Published: (2025-06-01) -
Modern Approach to Fabry Disease Diagnosis and Management in Children
by: Olga Ya. Smirnova, et al.
Published: (2024-02-01) -
Safety and Tolerability of a Shorter Agalsidase Beta Infusion Time in Patients with Classic or Later-Onset Fabry Disease
by: Dominique P. Germain, et al.
Published: (2024-11-01)